| Entry |
|
|---|
| Name |
Tegafur and uracil;
Uftoral (TN) |
|---|
| Formula |
C8H9FN2O3. C4H4N2O2
|
|---|
| Exact mass |
312.087
|
|---|
| Mol weight |
312.2538
|
|---|
| Structure |
|
|---|
| Component |
|
|---|
| Remark |
| Therapeutic category: | 4229 |
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC53 Tegafur, combinations
D02131 Tegafur and uracil <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
422 Antimetabolites
4229 Others
D02131 Tegafur and uracil
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 N4x N 29.1891 -16.3160
2 C8y C 27.9706 -15.6225
3 C8y C 29.1891 -17.7209
4 C8x C 26.7699 -16.3220
5 O5x O 27.9706 -14.2233
6 N4x N 27.9823 -18.4263
7 O5x O 30.4074 -18.4147
8 C8x C 26.7699 -17.7268
9 C1y C 20.0900 -18.4100
10 O2x O 18.9700 -17.6400
11 C1x C 19.6700 -19.7400
12 C1x C 17.8500 -18.4100
13 C1x C 18.2700 -19.7400
14 N4y N 21.4900 -17.6400
15 C8y C 22.6800 -18.3400
16 C8x C 21.4900 -16.2400
17 N4x N 23.9400 -17.6400
18 O5x O 22.6800 -19.7400
19 C8y C 22.7500 -15.5400
20 C8y C 23.9400 -16.3100
21 O5x O 25.0600 -15.6100
22 X F 22.7500 -14.2100
BOND 23
1 1 2 1
2 1 3 1
3 2 4 1
4 2 5 2
5 3 6 1
6 3 7 2
7 4 8 2
8 6 8 1
9 9 10 1
10 9 11 1
11 10 12 1
12 11 13 1
13 12 13 1
14 14 15 1
15 14 16 1
16 15 17 1
17 15 18 2
18 16 19 2
19 17 20 1
20 20 21 2
21 19 20 1
22 19 22 1
23 9 14 1
|
|---|
